Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
November 22 2022 - 8:00AM
Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical
company focused on transforming medicines to transform lives,
announced today that members of management will participate in the
following upcoming investor conferences:
- Piper Sandler 34th
Annual Healthcare Conference: Fireside chat on Tuesday, November 29
at 3:30 p.m. ET.
- Evercore ISI
HealthCONx Conference: Fireside chat on Thursday, December 1 at
2:40 PM ET.
A live webcast of these events, as well as archived recordings,
will be available on Avadel’s Investor Relations website,
investors.avadel.com, for 90 days following each conference.
About Avadel Pharmaceuticals plc
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical
company focused on transforming medicines to transform lives. Our
approach includes applying innovative solutions to the development
of medications that address the challenges patients face with
current treatment options. Our current lead drug candidate,
LUMRYZ™, is an investigational formulation of sodium oxybate
leveraging our proprietary drug delivery technology and designed to
be taken once at bedtime for the treatment of cataplexy or
excessive daytime sleepiness in adults with narcolepsy. For more
information, please visit www.avadel.com.
Investor Contact:Courtney TurianoStern Investor
Relations, Inc.Courtney.Turiano@sternir.com (212) 698-8687
Media Contact:Gabriella GreigReal
Chemistryggreig@realchemistry.com(203) 249-2688
Avadel Pharmaceuticals (NASDAQ:AVDL)
Historical Stock Chart
From Apr 2024 to May 2024
Avadel Pharmaceuticals (NASDAQ:AVDL)
Historical Stock Chart
From May 2023 to May 2024